418 Seizures and Epilepsy Flashcards
Mechanisms of action of phenytoin [2] (H20 C418 P3517)
Inhibition of Na+-dependent action potentials in a frequency-dependent manner
Inhibition of voltage-gated Ca2+ channels
Mechanism of action of carbamazepine (H20 C418 P3517)
Inhibition of Na+-dependent action potentials in a frequency-dependent manner
Mechanisms of action of lamotrigine [2] (H20 C418 P3517)
Inhibition of Na+-dependent action potentials in a frequency-dependent manner
Attenuation of glutamate activity
Mechanisms of action of topiramate [2] (H20 C418 P3517)
Inhibition of Na+-dependent action potentials in a frequency-dependent manner
Attenuation of glutamate activity
Mechanism of action of zonisamide (H20 C418 P3517)
Inhibition of Na+-dependent action potentials in a frequency-dependent manner
Mechanism of action of lacosamide (H20 C418 P3517)
Inhibition of Na+-dependent action potentials in a frequency-dependent manner
Mechanism of action of rufinamide (H20 C418 P3517)
Inhibition of Na+-dependent action potentials in a frequency-dependent manner
Mechanisms of action of gabapentin [2] (H20 C418 P3517)
Inhibition of voltage-gated Ca2+ channels
Increase in the availability of GABA
Mechanism of action of pregabalin (H20 C418 P3517)
Inhibition of voltage-gated Ca2+ channels
Mechanism of action of ezogabine (H20 C418 P3517)
Facilitating the opening of potassium channels
Mechanism of action of felbamate (H20 C418 P3517)
Attenuation of glutamate activity
Mechanism of action of benzodiazepines (H20 C418 P3517)
Potentiation of GABA receptor function
Mechanism of action of barbiturates (H20 C418 P3517)
Potentiation of GABA receptor function
Mechanisms of action of valproic acid [2] (H20 C418 P3517)
Increase in the availability of GABA
Inhibition of T-type Ca2+ channels in thalamic neurons
Mechanism of action of tiagabine (H20 C418 P3517)
Increase in the availability of GABA